Surgical Site Infections and the Microbiome: Understanding the Pathogenesis of Surgical Site Infections
1 other identifier
observational
300
1 country
1
Brief Summary
This is a prospective, observational study of patients undergoing open GI surgery. At the time of operation, samples will be collected from the incision site and GI tract. The study will follow patients up to 30 days postoperatively, monitoring for signs of SSI. Samples will be taken from all patients who develop SSI. Sequencing will be performed on a subset of samples based on our specific aims.
- Aim 1: conduct a case-control study of patients with SSI and age-, sex-, diagnosis-, and wound class-matched control patients without SSI, comparing microbiome alpha diversity and community composition with 16S RNA sequencing to determine the association with SSI.
- Aim 2: identify the strain of bacteria isolated from SSIs using shotgun metagenomic sequencing and determine whether the specific strain was present in the skin and gut at the time of operation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2024
CompletedFirst Posted
Study publicly available on registry
March 8, 2024
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2026
ExpectedMay 26, 2026
May 1, 2026
2.2 years
March 1, 2024
May 22, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
alpha diversity composition
Alpha diversity composition at the surgical incision site at multiple time points
Baseline, Day 30 post-op
microbial community composition
microbial community composition at the surgical incision site at multiple time points
Baseline, Day 30 post-op
pathogenic strain of bacteria
Pathogenic strain of bacteria at SSI compared with pathogens isolated from skin and/or GI tract microbiome
Baseline, Day 30 post-op
Study Arms (2)
Patients undergoing open GI surgery
Patients with SSI
Control group
age-, sex-, diagnosis-, and wound class-matched control patients without SSI
Interventions
samples from the incision site and GI tract collected
Eligibility Criteria
adults over the age of 18 years, who are undergoing open abdominal surgery with a midline incision.
You may qualify if:
- We will include adult patients (age ≥ 18 years)
- Undergoing open abdominal surgery during the study period.
- Open abdominal surgery will include any abdominal procedure entering the peritoneal cavity through a midline incision with a skin incision that is 5cm or greater.
You may not qualify if:
- Patients with planned minimally invasive surgery including laparoscopic or robotic surgery as these patients have lower rates of surgical site infections (SSIs). Patients who have a laparoscopic or robotic surgery converted to open surgery will be excluded.
- Appendectomy and cholecystectomy as these patients have lower risk of SSI.
- Vascular, gynecological, obstetric, urological or transplantation.
- Trauma patients.
- Patients without source control at the index operation including those with an open abdomen, no fascial closure, or temporary abdominal closure device (such as abthera dressing).
- Pediatric patients (age\<18 years).
- Patients who decline swab/specimen collection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55414, United States
Biospecimen
samples from the incision site and GI tract
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Rickard
University of Minnesota
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2024
First Posted
March 8, 2024
Study Start
April 1, 2024
Primary Completion
June 15, 2026
Study Completion (Estimated)
July 30, 2026
Last Updated
May 26, 2026
Record last verified: 2026-05